CYP3A5 is induced by corticosteroids in the liver and can both induce drug resistance and activate prodrugs; it is the subject of ongoing studies in several neoplasias [93] and could represent a viable drug target for corticotrope adenomas from female patients. This evidence concerns the gene CYP3A5 and adenoma.